PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.85%
Negative revenue growth while Healthcare median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-2.33%
Negative gross profit growth while Healthcare median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
-21.34%
Negative EBIT growth while Healthcare median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-23.85%
Negative operating income growth while Healthcare median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
-21.96%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-22.00%
Negative EPS growth while Healthcare median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-22.00%
Negative diluted EPS growth while Healthcare median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
0.06%
Share growth above Healthcare median by more than 2x. Jim Chanos would suspect over-dilution or repeated equity raises.
0.06%
Diluted share growth above 2x Healthcare median. Jim Chanos would suspect undue issuance or heavy employee stock compensation.
No Data
No Data available this quarter, please select a different quarter.
5.15%
OCF growth of 5.15% while Healthcare is zero. Walter Schloss might see a modest positive difference, which can compound over time.
5.15%
FCF growth of 5.15% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
170.42%
10Y CAGR of 170.42% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
62.00%
5Y CAGR of 62.00% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
34.07%
3Y CAGR of 34.07% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
99.06%
Net income/share CAGR exceeding 1.5x Healthcare median of 13.39% over a decade. Joel Greenblatt might see a standout compounder of earnings.
23.20%
5Y net income/share CAGR > 1.5x Healthcare median of 7.41%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
-9.07%
Negative 3Y CAGR while Healthcare median is 6.40%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
341.28%
Equity/share CAGR of 341.28% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
88.66%
5Y equity/share CAGR of 88.66% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
40.10%
3Y equity/share CAGR of 40.10% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
140.00%
Dividend/share CAGR of 140.00% while Healthcare is zero. Walter Schloss sees a minor improvement that could compound if the firm maintains consistent raises.
166.67%
5Y dividend/share CAGR of 166.67% while Healthcare is zero. Walter Schloss sees at least some improvement that could compound over time.
9.09%
3Y dividend/share CAGR of 9.09% while Healthcare is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
5.48%
AR growth of 5.48% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
6.87%
Inventory growth of 6.87% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
0.24%
Asset growth of 0.24% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
2.53%
Positive BV/share change while Healthcare median is negative. Peter Lynch finds a strong advantage vs. peers failing to expand equity.
-5.67%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
2.76%
SG&A growth of 2.76% while Healthcare median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.